Diagnostic Imaging's A Look Ahead: June 14 to June 18, 2021
Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon:
The Society of Nuclear Medicine and Molecular Imaging 2021 annual meeting wraps up this week. Look for continuing coverage of the latest research and developments from speakers and investigators.
For more SNMMI 2021 coverage, click here.
The conversation about the long-term impacts of head injuries sustained by football players has been swirling for decades. How they affect the brain and whether they lead to neurological dysfunction later in life are questions that have fueled a multitude of investigations. Later this week, look for an article based on a study that addresses this topic.
For more neurological imaging coverage, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Women in radiation oncology are lagging behind in numbers compared to other specialties. Look for an article this week that discusses novel interventions detailed in Advances in Radiation Oncology that are designed to increase recruitment.
For more content on women in radiology, click here.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
